Frost Phillip MD Et al - 04 Sep 2025 Form 4/A - Amendment Insider Report for Fluent, Inc. (FLNT)

Reporting relationship: 10%+ Owner
Issuer ticker: FLNT
Reported as of: 04 Sep 2025
Net transaction value: +$286
SEC form: 4/A - Amendment
Accepted by SEC: 12 Sep 2025, 16:30:19 UTC
Original report date: 08 Sep 2025
Prior SEC filing: 21 Aug 2025
Next SEC filing: 15 Sep 2025
Source filing: View source filing
Reporting owner signature: /s/ Dr. Phillip Frost, M.D., Trustee

Key filing fact

Frost Phillip MD Et al filed Form 4/A - Amendment for Fluent, Inc. (FLNT) on 12 Sep 2025.

Key facts

This page summarizes Frost Phillip MD Et al's Form 4/A - Amendment filing for Fluent, Inc. (FLNT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 12 Sep 2025, 16:30.

Change

Previous filing in this sequence was filed on 21 Aug 2025.
Current net transaction value: +$286.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (2)

CIK 0000898860 Primary reporting owner

FROST PHILLIP MD ET AL

Relationship: 10%+ Owner
Address: 4400 BISCAYNE BLVD, MIAMI
Signature: /s/ Dr. Phillip Frost, M.D., Trustee
Signature date: 12 Sep 2025

CIK 0001380896

Frost Gamma Investments Trust

Relationship: 10%+ Owner
Address: 4400 BISCAYNE BLVD, MIAMI
Signature: /s/ Dr. Phillip Frost, M.D., Individually
Signature date: 12 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

FLNT transaction

Common Stock

Other

Transaction value: $286
Shares: +571,429
Change %: +9.9%
Price: $0.000500
Shares after: 6,318,439
Date: 04 Sep 2025
Ownership: Held by Frost Gamma Investments Trust
Footnotes: F1, F2

FLNT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 8,334
Date: 04 Sep 2025
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Footnote F2

On September 8, 2025, the reporting person filed a Form 4 reporting ownership of 7,294,403 shares of Common Stock following the reported transaction. The reporting person's ownership of Common Stock following the transaction should have been reported as 6,318,439.